INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 188 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $48,979 | -36.4% | 61,827 | +25.3% | 0.00% | – |
| Q4 2022 | $76,966 | +113.8% | 49,337 | +134.3% | 0.00% | – |
| Q3 2022 | $36,000 | -92.5% | 21,056 | -83.7% | 0.00% | – |
| Q1 2019 | $482,000 | -2.6% | 129,102 | +4.3% | 0.00% | -100.0% |
| Q4 2018 | $495,000 | -62.2% | 123,817 | -17.7% | 0.00% | -50.0% |
| Q1 2016 | $1,310,000 | +41.8% | 150,437 | +9.5% | 0.00% | +100.0% |
| Q4 2015 | $924,000 | – | 137,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 581,100 | $2,324,000 | 2.21% |
| Round Table Services, LLC | 339,391 | $1,358,000 | 0.52% |
| ARK Investment Management | 1,885,641 | $7,543,000 | 0.31% |
| WASATCH ADVISORS LP | 5,337,930 | $21,352,000 | 0.28% |
| Cedar Brook Financial Partners, LLC | 41,500 | $166,000 | 0.10% |
| Unified Trust Company, N.A. | 13,716 | $54,000 | 0.05% |
| Virtus ETF Advisers LLC | 60,398 | $242,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 394,703 | $1,579,000 | 0.04% |
| FOX RUN MANAGEMENT, L.L.C. | 14,465 | $58,000 | 0.03% |
| BREWIN DOLPHIN LTD | 59,123 | $236,492 | 0.03% |